Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-23-016046

CBO & EVP sold 1,968 shares at $45.27 ($89,091)

  • CBO & EVP returned 3,394 shares (to the company)
  • CBO & EVP acquired 24,663 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kassberg Thomas Richard CBO & EVP 2023-03-01 Grant or award +2,663 230,222 D: show line 1 in the form
Kassberg Thomas Richard CBO & EVP 2023-03-01 Grant or award +22,000 252,222 D: show line 2 in the form
Kassberg Thomas Richard CBO & EVP 2023-03-01 Sale −1,968 $45.27 $89,091 250,254 D: show line 3 in the form
Kassberg Thomas Richard CBO & EVP 2023-03-01 Returned to the company −3,394 $45.65 $154,936 246,860 D: show line 4 in the form
Open-market sales · 1,968 sh · avg $45.27 · $89,091

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kassberg Thomas Richard CBO & EVP 2023-03-01 Grant or award · Stock Option (Right to Buy) +39,400 39,400 D: show line 5 in the form
Loading xslF345X03/doc4.xml…